1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Germany >
  5. SK bioscience Acquires IDT Biologika

Add-on Acquisition • Life Science

SK bioscience Acquires IDT Biologika

On October 2, 2024, SK bioscience acquired life science company IDT Biologika

Acquisition Context
  • This is SK bioscience’s 1st transaction in the Life Science sector.
  • This is SK bioscience’s 1st transaction in Germany.

Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary
Date October 2, 2024
Target IDT Biologika
Sector Life Science
Buyer(s) SK bioscience
Deal Type Add-on Acquisition

Target Company

IDT Biologika

Dessau-Rosslau, Germany
IDT Biologika is a life science company. IDT Biologika offers research, development and manufacturing of biologics for the global protection of human and animal health. IDT Biologika was founded in 1921 and is based in Dessau-Rosslau, Germany.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

SK bioscience

Seongnam-si, South Korea
Category Company
Sector Life Science
DESCRIPTION

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure. SK bioscience is based in Seongnam-si, South Korea.

Deal Context for Buyer #
Overall 1 of 2
Sector: Life Science 1 of 2
Type: Add-on Acquisition 1 of 1
Country: Germany 1 of 1
Year: 2024 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-10-08 FinaBio

Rockville, Maryland, United States

FinaBio specializes in the research and development of conjugate vaccines for pneumoniae, meningococcal, typhoid, and other diseases. FinaBio was founded in 2006 and is based in Rockville, Maryland.

Buy -

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Germany M&A - 2024 M&A

Mergr

Solution for

Product

Company

Legal